AARDEX still confirms its leading position in the B2B medication adherence market, closing steadily more new deals with Pharma Companies, Biotech’s, Excellence Centers and Universities, over 30 countries in 2018.
Breaking News
Taming the black dog: Managing the challenge of poor adherence among patients with depression
They might not always be easily identifiable, but millions of people across the globe are living with the debilitating symptoms of depression. This common mental disorder is thought to affect around 5% of the world’s adult population, with the pandemic
Oksana Pidmogylna
March 20, 2025
